Einat Brill Almon
2014
In 2014, Einat Brill Almon earned a total compensation of $678.8K as Senior Vice President, Product Development at Protalix BioTherapeutics, a 27% decrease compared to previous year.
Compensation breakdown
| Bonus | $85,000 |
|---|---|
| Option Awards | $56,170 |
| Salary | $263,917 |
| Stock Awards | $205,244 |
| Other | $68,489 |
| Total | $678,820 |
Almon received $263.9K in salary, accounting for 39% of the total pay in 2014.
Almon also received $85K in bonus, $56.2K in option awards, $205.2K in stock awards and $68.5K in other compensation.
Rankings
In 2014, Einat Brill Almon's compensation ranked 9,184th out of 13,032 executives tracked by ExecPay. In other words, Almon earned more than 29.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,184 out of 13,032 | 30th |
Division Manufacturing | 3,445 out of 4,965 | 31st |
Major group Chemicals And Allied Products | 1,165 out of 1,690 | 31st |
Industry group Drugs | 924 out of 1,369 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 168 out of 241 | 30th |
Source: SEC filing on March 16, 2017.
Almon's colleagues
We found four more compensation records of executives who worked with Einat Brill Almon at Protalix BioTherapeutics in 2014.
2014
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2014
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2014
Tzvi Palash
Protalix BioTherapeutics
Chief Operating Officer
2014
Moshe Manor
Protalix BioTherapeutics